The Greenberg Traurig team successfully obtained an EB-1 extraordinary ability green card for an individual that specializes in using venture capital and the start-up ecosystem to fund research of novel cancer therapies. Without this foreign national’s unique expertise and talents, many small companies would not be able to obtain funding for their cancer research. GT’s experience with EB-1 petitions, along with extensive research, allowed the team to present an EB-1 green card application to United States Citizenship and Immigration Services (USCIS) that thoroughly demonstrated this employee’s cutting-edge accomplishments and expertise, including the individual’s original contributions of major significance to the venture capital, healthcare, and biotechnology industries. USCIS approved the case and agreed that the employee was an individual with extraordinary ability who enjoys international recognition, and whose accomplishments surpass those of the majority in the same field.

*Past results are not guaranteed.